Related references
Note: Only part of the references are listed.Safety and Efficacy of Pimecrolimus in Atopic Dermatitis: A 5-Year Randomized Trial
Bardur Sigurgeirsson et al.
PEDIATRICS (2015)
Complementary and Alternative Medicines and Childhood Eczema: A US Population-Based Study
Jonathan I. Silverberg et al.
DERMATITIS (2014)
Are the concepts of induction of remission and treatment of subclinical inflammation in atopic dermatitis clinically useful?
Ting Seng Tang et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Guidelines of care for the management of atopic dermatitis Section 2. Management and treatment of atopic dermatitis with topical therapies
Lawrence F. Eichenfield et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
Epidermal Permeability Barrier Defects and Barrier Repair. Therapy in Atopic Dermatitis
Hae-Jin Lee et al.
ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2014)
Topical Calcineurin Inhibitors and Lymphoma Risk: Evidence Update with Implications for Daily Practice
Elaine C. Siegfried et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2013)
Atopic dermatitis: A practice parameter update 2012
Lynda Schneider et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Topical Calcineurin Inhibitors for Atopic Dermatitis: Review and Treatment Recommendations
Warner W. Carr
PEDIATRIC DRUGS (2013)
CSACI position statement: safety of topical calcineurin inhibitors in the management of atopic dermatitis in children and adults
Audrey O. Segal et al.
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY (2013)
Gene expression is differently affected by pimecrolimus and betamethasone in lesional skin of atopic dermatitis
J. M. Jensen et al.
ALLERGY (2012)
Long-term efficacy and tolerability of tacrolimus 0.03% ointment in infants:* a two-year open-label study
Johanna M. Mandelin et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2012)
Guidelines for treatment of atopic eczema (atopic dermatitis) Part I
J. Ring et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2012)
Evaluation of cancer risk related to atopic dermatitis and use of topical calcineurin inhibitors
P. Tennis et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency
H. Aubert-Wastiaux et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
Differential suppression of epidermal antimicrobial protein expression in atopic dermatitis and in EFAD mice by pimecrolimus compared to corticosteroids
Jens-Michael Jensen et al.
EXPERIMENTAL DERMATOLOGY (2011)
Evaluation of the atrophogenic potential of hydrocortisone 1% cream and pimecrolimus 1% cream in uninvolved forehead skin of patients with atopic dermatitis using optical coherence tomography
Roland Aschoff et al.
EXPERIMENTAL DERMATOLOGY (2011)
The Atopic March: Progression from Atopic Dermatitis to Allergic Rhinitis and Asthma
Tao Zheng et al.
ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2011)
Quality-of-life Outcomes and Measurement in Childhood Atopic Dermatitis
Sarah L. Chamlin et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2010)
The Safety and Efficacy of Tacrolimus Ointment in Pediatric Patients with Atopic Dermatitis
Alexandra D. McCollum et al.
PEDIATRIC DERMATOLOGY (2010)
Infant Skin Microstructure Assessed In Vivo Differs from Adult Skin in Organization and at the Cellular Level
Georgios N. Stamatas et al.
PEDIATRIC DERMATOLOGY (2010)
Association Between Exposure to Topical Tacrolimus or Pimecrolimus and Cancers
Rita L. Hui et al.
ANNALS OF PHARMACOTHERAPY (2009)
Topical Treatments with Pimecrolimus, Tacrolimus and Medium- to High-Potency Corticosteroids, and Risk of Lymphoma
Sebastian Schneeweiss et al.
DERMATOLOGY (2009)
The pharmacokinetics of tacrolimus after first and repeated dosing with 0.03% ointment in infants with atopic dermatitis
Sakari Reitamo et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2009)
Lymphoma among patients with atopic dermatitis and/or treated with topical immunosuppressants in the United Kingdom
Felix M. Arellano et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis (Reprinted from J Allergy Clin Immunol vol 123, pg 1124-33, 2009)
Jens-Michael Jensen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Efficacy and safety of fluticasone propionate 0.005% ointment in the long-term maintenance treatment of children with atopic dermatitis: Differences between boys and girls?
Eltjo J. Glazenburg et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2009)
Twice-daily versus Once-daily Applications of Pimecrolimus Cream 1% for the Prevention of Disease Relapse in Pediatric Patients with Atopic Dermatitis
Mireille Ruer-Mulard et al.
PEDIATRIC DERMATOLOGY (2009)
Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient:: a multicentre, randomized, double-blind, controlled study
A. Peserico et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
Proactive disease management with 0.03% tacrolimus ointment for children with atopic dermatitis: results of a randomized, multicentre, comparative study
D. Thaci et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
Basis for the barrier abnormality in atopic dermatitis: Outside-inside-outside pathogenic mechanisms
Peter M. Elias et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
The prevalence of atopic triad in children with physician-confirmed atopic dermatitis
Roger Kapoor et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
Mechanisms of disease: Atopic dermatitis
Thomas Bieber
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The socioeconomic impact of atopic dermatitis in the United States: A systematic review
Anthony J. Mancini et al.
PEDIATRIC DERMATOLOGY (2008)
Three Times Weekly Tacrolimus Ointment Reduces Relapse in Stabilized Atopic Dermatitis: A New Paradigm for Use
Amy S. Paller et al.
PEDIATRICS (2008)
Control of atopic eczema with pimecrolimus cream 1% under daily practice conditions:: results of a > 2000 patient study
J. Ring et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2008)
Blood concentrations, tolerability and efficacy of pimecrolimus cream 1% in Japanese infants and children with atopic dermatitis
Lawrence F. Eichenfield et al.
JOURNAL OF DERMATOLOGY (2007)
Stealth monitoring of adherence to topical medication: Adherence is very poor in children with atopic dermatitis
Jennifer Krejci-Manwaring et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2007)
Risk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitis
Felix M. Arellano et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
Lack of association between exposure to topical calcineurin inhibitors and skin cancer in adults
David J. Margolis et al.
DERMATOLOGY (2007)
An update on the safety and tolerability of pimecrolimus cream 1%: Evidence from clinical trials and post-marketing surveillance
Richard G. B. Langley et al.
DERMATOLOGY (2007)
Clinical management of atopic eczema with pimecrolimus cream 1% (Elidel (R)) in paediatric patients
Lawrence F. Eichenfield et al.
DERMATOLOGY (2007)
Quality of life and childhood atopic dermatitis: the misery of living with childhood eczema
S. Lewis-Jones
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2006)
Treatment of paediatric atopic dermatitis with pimecrolimus (Elidel®, SDZ ASM 981):: impact on quality of life and health-related quality of life
SP McKenna et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2006)
Low systemic exposure in infants with atopic dermatitis in a 1-year pharmacokinetic study with pimecrolimus cream
M Lakhanpaul et al.
EXPERIMENTAL DERMATOLOGY (2006)
Safety and tolerability of 1% pimecrolimus cream among infants: Experience with 1133 patients treated for up to 2 years
C Paul et al.
PEDIATRICS (2006)
Adverse effects of topical glucocorticosteroids
UR Hengge et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)
Review of the potential photo-cocarcinogenicity of topical calcineurin inhibitors -: Position statement of the European dermatology forum
J Ring et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2005)
Treatment of infants with atopic eczema with pimecrolimus cream 1% improves parents' quality of life:: A multicenter, randomized trial
D Staab et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2005)
Low systemic absorption and good tolerability of pimecrolimus, administered as 1% cream (Elidel®) in infants with atopic dermatitis -: A multicenter, 3-week, open-label study
D Staab et al.
PEDIATRIC DERMATOLOGY (2005)
Report of the topical calcineurin inhibitor task force of the American College of Allergy, Asthma and Immunology and the American Academy of Allergy, Asthma and Immunology
L Fonacier et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2005)
Long-term control of atopic dermatitis with pimecrolimus cream 1% in infants and young children:: A two-year study
KA Papp et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2005)
Long-term treatment of atopic dermatitis with pimecrolimus cream 1% in infants does not interfere with the development of protective antibodies after vaccination
KA Papp et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2005)
Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis
T Hultsch et al.
DERMATOLOGY (2005)
The natural course of atopic dermatitis from birth to age 7 years and the association with asthma
S Illi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Lymphomas after solid organ transplantation:: A collaborative transplant study report
G Opelz et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Low-dose immunosuppression reduces the incidence of post-transplant lymphoproliferative disease in pediatric liver graft recipients
R Ganschow et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2004)
Percutaneous absorption of drugs used in atopic eczema:: pimecrolimus permeates less through skin than corticosteroids and tacrolimus
A Billich et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2004)
Pimecrolimus - an anti-inflammatory drug targeting the skin
M Grassberger et al.
EXPERIMENTAL DERMATOLOGY (2004)
Onset of action of pimecrolimus cream 1% in the treatment of atopic eczema in infants
R Kaufmann et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Systemic exposure, tolerability, and efficacy of pimecrolimus cream 1% in atopic dermatitis patients
BR Allen et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2003)
Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study
J Berth-Jones et al.
BRITISH MEDICAL JOURNAL (2003)
Safety and efficacy of nonsteroid pimecrolimus cream 1% in the treatment of atopic dermatitis in infants
VC Ho et al.
JOURNAL OF PEDIATRICS (2003)
The benefit of pimecrolimus (Elidel, SDZ ASM 981) on parents' quality of life in the treatment of pediatric atopic dermatitis
D Whalley et al.
PEDIATRICS (2002)
Tacrolimus ointment for the treatment of atopic dermatitis is not associated with an increase in cutaneous infections
AB Fleischer et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2002)
Intermittent dosing of fluticasone propionate cream for reducing the risk of relapse in atopic dermatitis patients
J Hanifin et al.
BRITISH JOURNAL OF DERMATOLOGY (2002)
Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug
A Kapp et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2002)
First experience of topical SDZ ASM 981 in children with atopic dermatitis
J Harper et al.
BRITISH JOURNAL OF DERMATOLOGY (2001)
The new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks: a randomized, double-blind controlled study
C Queille-Roussel et al.
BRITISH JOURNAL OF DERMATOLOGY (2001)
Topical corticosteroid phobia in patients with atopic eczema
CR Charman et al.
BRITISH JOURNAL OF DERMATOLOGY (2000)
Share Paper
